Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 2/20 | 0.48 |
| ▸ | CTSL | P07711 | 8/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.48 |
| ▸ | CTSV | O60911 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 4/20 | 0.47 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10118968 | 0.96 | CTSL (0.50) | PSMB5CTSLCTSSCTSVCTSK | |
| SCHEMBL10118970 | 0.92 | PSMB5 (0.56) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL10118862 | 0.92 | PSMB5 (0.56) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL10118845 | 0.89 | CTSB (0.52) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL10118851 | 0.89 | CTSB (0.52) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL10118994 | 0.89 | CTSB (0.51) | PSMB5CTSLCTSSCTSVCTSK | |
| SCHEMBL10118965 | 0.89 | LMNA (0.53) | PSMB5CTSLCTSSCTSVCTSK | |
| SCHEMBL10118859 | 0.88 | CTSL (0.51) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL10118811 | 0.87 | CTSB (0.57) | PSMB5CTSLCTSSCTSKCTSB | |
| SCHEMBL12516880 | 0.84 | PSMB5 (0.56) | PSMB5CTSLCTSSCTSVCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012004554-A1 | ALDEHYDE COMPOUNDS AS INHIBITORS OF DUST MITE GROUP 1 PEPTIDASE ALLERGEN AND THEIR USE | ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) | 2012-01-12 | — | — | WO | disclosed |